Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ largest » _ large (Expand Search)
day mean » may mean (Expand Search), daily mean (Expand Search), data mean (Expand Search)
Showing 1 - 20 results of 30,604 for search '(( day mean decrease ) OR ((( _ largest decrease ) OR ( _ ((a decrease) OR (nn decrease)) ))))', query time: 0.59s Refine Results
  1. 1
    Average days (mean) to heal a wound in 2022 and 2023.

    Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Claudin V is decreased following infection with Mtb.

    Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

    Published 2024
    “…Representative images of the frontal cortex (A–D), cerebral nuclei (F–I), brain stem (K–N), thalamus (P–S), and hippocampus (U–X) 15 days post-infection are shown. …”
    Save to List
    Saved in:
  3. 3
    Pregnancy-induced decrease in maternal serum BUN and IFN-

    Pregnancy-induced decrease in maternal serum BUN and IFN- by Haruka Mizobuchi (5395394)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Sleep deprivation increased inflammatory cytokines and decreased corticosterone in the blood.

    Sleep deprivation increased inflammatory cytokines and decreased corticosterone in the blood. by Weiran Shan (16969688)

    Published 2025
    Save to List
    Saved in:
  5. 5
    HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion.

    HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

    Published 2024
    Save to List
    Saved in:
  6. 6
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Heteroscedastic linear mixed model main results, estimating the volume (ml) of beer sold per day on the transformed (cube root) scale, on the original scale and on the relative scale, covariate coefficients shown in Table A in S3 Appendix (<i>n</i> = 12).

    Heteroscedastic linear mixed model main results, estimating the volume (ml) of beer sold per day on the transformed (cube root) scale, on the original scale and on the relative sca... by Eleni Mantzari (6991172)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  13. 13
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  14. 14
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Tetrandrine decreases Mtb antigen presentation.

    Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Selection frequencies plotted in decreasing order.

    Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Descriptives of the study sample, N = 451.

    Descriptives of the study sample, N = 451. by Orrin D. Ware (14829115)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  19. 19
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Puriton had the tendency of decreasing expressions of Th1 cell-related cytokines such as IFN-

    Puriton had the tendency of decreasing expressions of Th1 cell-related cytokines such as IFN- by So-Hyeon Bok (8066696)

    Published 2025
    Save to List
    Saved in:

Search Tools: